Meeder Asset Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8K | Sell |
50
-23,967
| -100% | -$863K | ﹤0.01% | 819 |
|
|
2025
Q1 | $947K | Buy |
24,017
+23,943
| +32,355% | +$944K | 0.06% | 137 |
|
|
2024
Q4 | $2.23K | Buy |
+74
| New | +$2.23K | ﹤0.01% | 885 |
|
|
2023
Q2 | – | Sell |
-803
| Closed | -$12.1K | – | 602 |
|
|
2023
Q1 | $12.1K | Buy |
+803
| New | +$12.1K | ﹤0.01% | 493 |
|
|
2021
Q2 | – | Sell |
-2,575
| Closed | -$123K | – | 2656 |
|
|
2021
Q1 | $123K | Buy |
+2,575
| New | +$123K | 0.01% | 861 |
|
|
2020
Q4 | – | Sell |
-5,571
| Closed | -$148K | – | 2217 |
|
|
2020
Q3 | $148K | Buy |
5,571
+251
| +5% | +$6.67K | 0.01% | 681 |
|
|
2020
Q2 | $105K | Buy |
5,320
+3,195
| +150% | +$63.1K | 0.01% | 753 |
|
|
2020
Q1 | $21K | Buy |
+2,125
| New | +$21K | ﹤0.01% | 1231 |
|
|
2019
Q3 | – | Sell |
-622
| Closed | -$5K | – | 2261 |
|
|
2019
Q2 | $5K | Buy |
+622
| New | +$5K | ﹤0.01% | 1680 |
|
|
2017
Q3 | – | Sell |
-315
| Closed | -$3K | – | 1758 |
|
|
2017
Q2 | $3K | Hold |
315
| – | – | ﹤0.01% | 1338 |
|
|
2017
Q1 | $4K | Sell |
315
-3,071
| -91% | -$39K | ﹤0.01% | 1181 |
|
|
2016
Q4 | $16K | Buy |
+3,386
| New | +$16K | ﹤0.01% | 685 |
|